✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchIndustry Why This Matters Federal rescheduling from Schedule I to Schedule III would remove barriers...
In the Mix: 5 More Articles — March 07, 2026
5 cannabis articles reviewed and scored below the CED clinical relevance threshold in the March 07, 2026 feed update. Organized by topic with summaries and source links.
Regulatory Digest 2026-03-06
✦ New Regulatory updates (higher clinical relevance) (100) [regulations.gov] Schedules of Controlled Substances: Rescheduling of Marijuana (85) [regulations.gov] Bulk Manufacturer-Royal Emerald (2024-11786) DEA1368 (85) [regulations.gov] Exempt Chemical Preparations May 2024 (2024-10465) –...